Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Preimplantation genetic testing for BRCA gene mutation carriers: a cost effectiveness analysis.

Reproductive biology and endocrinology : RB&E - 8 Oct 2021

Michaan Nadav, Leshno Moshe, Cohen Yoni, Safra Tamar, Peleg-Hasson Shira, Laskov Ido, Grisaru Dan

Abstract excerpt

BACKGROUND: Gynecologic oncologists should be aware of the option of conception through IVF/PGT-M for families with high BRCA related morbidity or mortality. Our objective was to investigate the cost-effectiveness of preimplantation genetic testing for selection and transfer of BRCA negative embryo in BRCA mutation carriers compared to natural conception. METHODS: Cost-effectiveness of two strategies, conception...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA2 Protein
Share to Cost-Benefit Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Embryo Transfer

Share to Fertilization in Vitro

Share to Genetic Carrier Screening

Share to Israel

Share to Preimplantation Diagnosis

Share to Quality-Adjusted Life Years

Source

Open in PubMed Open full text

Identifiers

PMID: 34620184
DOI: 10.1186/s12958-021-00827-9
PMCID: PMC8499576

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Preimplantation genetic testing for BRCA gene mutation carriers: a cost effectiveness analysis.PMID 34620184Read ↗

Cost effectiveness of in vitro fertilisation and preimplantation genetic testing to prevent transmission of BRCA1/2 mutations.Semantic proximity Read ↗

Preimplantation genetic testing for BReast CAncer gene 1 and risk-reducing surgery is more effective at age 35 than age 40.Semantic proximity Read ↗

An economic analysis of preimplantation genetic testing for aneuploidy by polar body biopsy in advanced maternal ageSemantic proximity Read ↗

Uptake of Preimplantation Genetic Diagnosis in Female BRCA1 and BRCA2 Mutation Carriers.Semantic proximity Read ↗

A SART data cost-effectiveness analysis of planned oocyte cryopreservation versus in vitro fertilization with preimplantation genetic testing for aneuploidy considering ideal family sizeSemantic proximity Read ↗

In Vitro Fertilization with Preimplantation Genetic Testing for Aneuploidy for Infertility in China: A Cost-Effectiveness AnalysisSemantic proximity Read ↗

Cost-effectiveness of testing for breast cancer susceptibility genes.Semantic proximity Read ↗

An Economic Analysis of Aneuploidy Screening of Oocytes in Assisted Reproduction in GermanySemantic proximity Read ↗

Does in vitro fertilization (IVF) treatment provide good value for money? A cost-benefit analysisSemantic proximity Read ↗

A MDP model for breast and ovarian cancer intervention strategies for BRCA1/2 mutation carriers.Semantic proximity Read ↗

Cost-effectiveness of preimplantation genetic testing for aneuploidy for women with subfertility in China: an economic evaluation using evidence from the CESE-PGS trialSemantic proximity Read ↗

Decision analysis of prophylactic surgery or screening for BRCA1 mutation carriers: a more prominent role for oophorectomy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.